Of 95 patients receiving transthoracic shocks for atrial flutter in the emergency department, about half were treated with a defibrillator that delivered monophasic-waveform shocks and the rest were ...

May 2, 2003 - A retrospective study and results of a phase 3 trial point to new approaches to both short-term cardioversion and long-term maintenance of patients with atrial fibrillation (AF).

When atrial flutter is seen with such a slow ventricular response (in this case, 9:1 conduction), there is concern for underlying complete heart block should the patient be restored to normal sinus ...

Clinical trial finds edoxaban to be equally effective as current use of warfarin. Clinical trial finds edoxaban to be equally effective as current use of warfarin. The results of the largest known ...

Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with atrial fibrillation scheduled for elective cardioversion, according to new research. Apixaban lowers the ...

VANCOUVER, Cardiome Pharma Corp. today announced that an independent study conducted by investigators at the University of Leipzig Heart Center,Germany, found that intravenous vernakalant facilitated ...

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...